AROC vs BTU

AROC's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. Despite strong profitability metrics and robust earnings growth, elevated debt levels and weak technical momentum weigh on overall health. The stock trades above the Graham Number of $16.59 but below the growth-based intrinsic value of $44.55, suggesting a fair valuation given growth expectations. Analysts are bullish with a $31.56 target, though insider selling and a low technical trend score introduce caution.

The Advanced Deterministic Scorecard reveals severe financial health concerns with a Piotroski F-Score of just 2/9, indicating weak operational and balance sheet performance. Despite a low forward P/E of 10.81 and a strong analyst recommendation of 'strong_buy', the company is unprofitable (negative net and operating margins), has deteriorating earnings (YoY EPS growth of -95.9%), and lacks key valuation benchmarks like a Graham Number or Altman Z-Score due to financial instability. While the balance sheet shows a healthy current ratio and low debt/equity, persistent losses, poor earnings predictability, and negative insider activity undermine any bullish case. The stock's recent price surge (+99.3% in 1Y) appears disconnected from fundamentals, increasing vulnerability to correction.